Pharming Analyst Ratings
Pharming Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 196% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 03/28/2023 | 220% | Oppenheimer | $36 → $40 | Maintains | Outperform |
| 03/27/2023 | 196% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 02/22/2023 | 196% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 02/16/2023 | 196% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 08/03/2023 | 196% | HC Wainwright公司 | →$37 | 重申 | →购买 |
| 03/28/2023 | 220% | 奥本海默 | $36→$40 | 维护 | 跑赢大盘 |
| 03/27/2023 | 196% | HC Wainwright公司 | →$37 | 重申 | →购买 |
| 02/22/2023 | 196% | HC Wainwright公司 | →$37 | 重申 | →购买 |
| 02/16/2023 | 196% | HC Wainwright公司 | →$37 | 重申 | →购买 |
What is the target price for Pharming (PHAR)?
Pharming(Phar)的目标价是多少？
The latest price target for Pharming (NASDAQ: PHAR) was reported by HC Wainwright & Co. on August 3, 2023. The analyst firm set a price target for $37.00 expecting PHAR to rise to within 12 months (a possible 196.00% upside). 5 analyst firms have reported ratings in the last year.
辉明(纳斯达克代码：PHAR)的最新目标价是由HC Wainwright&Co.于2023年8月3日报道的。这家分析公司将目标价定为37美元，预计法尔将在12个月内上涨(可能上涨196.00%)。去年有5家分析公司公布了评级。
What is the most recent analyst rating for Pharming (PHAR)?
Pharming(Phar)的最新分析师评级是多少？
The latest analyst rating for Pharming (NASDAQ: PHAR) was provided by HC Wainwright & Co., and Pharming reiterated their buy rating.
分析师对辉明(纳斯达克代码：PHAR)的最新评级是由HC Wainwright&Co.提供的，辉明重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Pharming (PHAR)?
Pharming(Phar)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pharming, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pharming was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Pharming的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Pharming的上一次评级是在2023年8月3日提交的，所以你应该预计下一次评级将在2024年8月3日左右的某个时候公布。
Is the Analyst Rating Pharming (PHAR) correct?
分析师评级Pharming(Phar)正确吗？
While ratings are subjective and will change, the latest Pharming (PHAR) rating was a reiterated with a price target of $0.00 to $37.00. The current price Pharming (PHAR) is trading at is $12.50, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Pharming(Phar)评级被重申为目标价在0.00美元至37.00美元之间。Pharming(Pharming)目前的交易价格为12.50美元，在分析师的预测范围内。